Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:
- Introduction (0:00)
- Overview of Prostate Cancer (3:00)
- Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)
- Potential Role of Capivasertib in Metastatic HSPC (27:22)
- Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39)
- Current and Future Role of Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic PC (1:09:14)
